Introduction Hundreds of thousands of premature neonates born in low-income countries are implicitly denied treatment each year. Studies from India show that treatment is rationed even for neonates born at 32 gestational age weeks (GAW), and multiple external factors influence treatment decisions. Is withholding of life-saving treatment for children born between 28 and 32 GAW acceptable from an ethical perspective?
Method A seven-step impartial ethical analysis, including outcome analysis of four accepted priority criteria: severity of disease, treatment effect, cost effectiveness and evidence for neonates born at 28 and 32 GAW.
Results The ethical analysis sketches out two possibilities: (a) It is not ethically permissible to limit treatment to neonates below 32 GAW when assigning high weight to health maximisation and overall health equality. Neonates below 32 GAW score high on severity of disease and efficiency and cost-effectiveness of treatment if one gives full weight to early years of a newborn life. It is in the child's best interest to be treated. (b) It can be considered ethically permissible if high weight is assigned to reducing inequality of welfare and maximising overall welfare and/or not granting full weight to early years of newborns is considered acceptable. From an equity-motivated health and welfare perspective, we would not accept (b), as it relies on accepting the lack of proper welfare policies for the poor and disabled in India.
Conclusion Explicit priority processes in India for financing neonatal care are needed. If premature neonates are perceived as worth less than other patient groups, the reasons should be explored among a broad range of stakeholders.
- priority setting
- allocation of healthcare resources
- healthcare economics
- newborns and minors
- prolongation of life and euthanasia
- cultural pluralism
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Funding University of Bergen, Norway and the Young Investigator Grant, Norwegian Research Council (Norheim). The researchers are independent of funders.
Competing interests None.
Ethics approval The project was accepted by the research ethics committee at the hospital and was approved by the Norwegian Social Science Data Services.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Joint observation in NICU (JOIN): study protocol of a clinical randomised controlled trial examining an early intervention during preterm care
- Optimising neonatal service provision for preterm babies born between 27 and 31 weeks gestation in England (OPTI-PREM), using national data, qualitative research and economic analysis: a study protocol
- Estimating neonatal length of stay for babies born very preterm
- The effects of a one-to-one nurse-to-patient ratio on the mortality rate in neonatal intensive care: a retrospective, longitudinal, population-based study
- Impact of managed clinical networks on NHS specialist neonatal services in England: population based study
- Incidence and severity of retinopathy of prematurity in Turkey
- Determinants of developmental outcomes in a very preterm Canadian cohort
- The effects of designation and volume of neonatal care on mortality and morbidity outcomes of very preterm infants in England: retrospective population-based cohort study
- Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection
- Improving infant outcomes through implementation of a family integrated care bundle including a parent supporting mobile application